benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.
Benign neoplasm of other and unspecified sites
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_OTHER_NOS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
903 |
4. Check minimum number of eventsNone |
903 |
5. Include endpoints |
1191 |
6. Filter based on genotype QC (FinnGen only) |
1191 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna locis aliis et non specificatis
Similar endpoints
↥List of similar endpoints to Benign neoplasm of other and unspecified sites based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and unspecified sites
- Benign neoplasms
- Benign neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 9119 | 5174 | 3872 |
Only index persons | 7706 | 4485 | 3221 |
Unadjusted period prevalence (%) | |||
Whole population | 0.13 | 0.15 | 0.11 |
Only index persons | 0.15 | 0.16 | 0.12 |
Median age at first event (years) | |||
Whole population | 50.01 | 50.24 | 49.59 |
Only index persons | 47.98 | 48.44 | 47.33 |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 1191 | 695 | 496 |
Unadjusted period prevalence (%) | 0.23 | 0.24 | 0.22 |
Median age at first event (years) | 49.14 | 47.16 | 51.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1071
- Matched controls
- 10709
LabWAS
↥Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_OTHER_NOS and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_OTHER_NOS | 1.242 [1.09, 1.41] | < 0.001 |
Birth year | 0.991 [0.98, 1.0] | 0.039 |
During the follow-up period (1.1.1998 — 31.12.2019), 549 out of 2966 females with CD2_BENIGN_OTHER_NOS died.
Males
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_BENIGN_OTHER_NOS | 1.366 [1.18, 1.57] | < 0.001 |
Birth year | 0.985 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 531 out of 2412 males with CD2_BENIGN_OTHER_NOS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_OTHER_NOS.N-year risk | Females | Males |
---|---|---|
1 | 0.159% | 0.289% |
5 | 0.643% | 1.611% |
10 | 1.644% | 3.828% |
15 | 3.185% | 6.966% |
20 | 5.527% | 11.602% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OTHER_NOS – Benign neoplasm of other and unspecified sites
GWS hits: 3